Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

UCSF Medical Center named to Honor Roll of nation's top hospitals

U.S. News & World Report ranks UCSF Health adult care among nation's top 10 hospitals in 7 specialties, Best in the West for neurology/neurosurgery and rheumatology.

1 Aug 2023

IN8bio opens new cancer research lab in Birmingham's Pepper Place

Birmingham's Pepper Place has a striking new addition to its teeming farmers' market and noted food offerings -; a multimillion-dollar cancer research laboratory.

1 Aug 2023

Black women weigh emerging risks of ‘creamy crack’ hair straighteners

Deanna Denham Hughes was stunned when she was diagnosed with ovarian cancer last year. She was only 32. She had no family history of cancer, and tests found no genetic link. Hughes wondered why she, an otherwise healthy Black mother of two, would develop a malignancy known as a "silent killer."

1 Aug 2023

New class of antibody could benefit patients with treatment-resistant cancers

A Cancer Research UK-funded clinical trial has shown, for the first time, that a new class of antibody could benefit cancer patients whose existing treatments have stopped working.

28 Jul 2023

Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer

Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called Barrett's esophagus (BE), is present in roughly seven percent of middle-aged adults, less than one percent of BE patients will progress to EAC, making it difficult to determine which individuals are at risk of developing this deadly cancer.

27 Jul 2023

NK:IO raises £1.2M, bringing total Seed funding to £5.1M, to advance pioneering NK cell therapy

New investment of £1.2M brings total Seed funding to £5.1M including Innovate UK grants of £1.9M.

From NK:IO Limited 25 Jul 2023

Study illuminates why obesity makes ovarian cancer more deadly

Most women with ovarian cancer are diagnosed with the most advanced form of the disease. Less than a third of those diagnosed with the disease survive five years later. As the third most common type of gynecological cancer, it led to more than 200,000 reported deaths globally in 2020 alone, according to a recent study.

20 Jul 2023

Doctors urge more research on the use of psilocybin and other psychedelics for women’s cancer distress

It's time to stop prevaricating and explore the use of psilocybin—the active ingredient in 'magic mushrooms'—and other psychedelics to ease the often overwhelming distress faced by women with late stage gynecological cancers, urge doctors in a commentary published online in the International Journal of Gynecological Cancer.

19 Jul 2023

Immunodiagnosis: Unleashing the potential of personalized immunotherapy

Researchers discuss the concept of immunodiagnosis and explores the potential of artificial intelligence in ID systems for precise tumor immunotherapy.

18 Jul 2023

The potential prognostic role of AhRR and PPP1R3C expression in serous ovarian cancer

Study evaluated genes with copy number alterations to identify biomarkers for ovarian cancer prognosis.

18 Jul 2023

Synoptic reports improve completeness of pretreatment CT reports in advanced ovarian cancer

According to an accepted manuscript published in the American Journal of Roentgenology (AJR), a synoptic report improved completeness of pretreatment CT reports in patients with advanced ovarian cancer, including for established sites of unresectable or challenging-to-resect disease.

13 Jul 2023

Researchers develop first therapy of its kind to treat cisplatin-resistant prostate cancer

Prostate cancer is a leading cause of death among American men, and it's resistant to one of the most powerful chemotherapy medications -; cisplatin.

12 Jul 2023

Imperial spinout NK:IO awarded £1.6M Innovate UK New Cancer Therapeutics grant for development of pioneering NK cell therapy

NK:IO, a leader in NK cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumors, today announced it has been awarded £1.6M in grant funding from Innovate UK’s New Cancer Therapeutics program.

From NK:IO Limited 11 Jul 2023

Women with certain job roles may be associated with heightened risk of ovarian cancer

Hairdressers, beauticians, and accountants are among certain job roles that may be associated with a heightened risk of ovarian cancer, finds a case-control study published online in the journal Occupational & Environmental Medicine.

10 Jul 2023

Study uncovers three previously unknown membrane proteins in ovarian cancer

A study led by Nagoya University in Japan has identified three previously unknown membrane proteins in ovarian cancer.

7 Jul 2023

Adopting a 30th birthday genetic profile test could save lives and NHS costs

A new study published in the US medical journal ‘The Annals of Internal Medicine’ makes a very strong case for universal genetic testing at the age of 30.

24 Jun 2023

3D models of ovarian cancer reveal how cell’s location can affect tumor biology

Using 3-D models of ovarian cancer tumors, scientists found differences in gene activity based on where a cell is in a tumor, demonstrating how a cell's location and environment in a cancerous tumor can strongly influence which genes are active and the cell's role in the cancer's biology.

23 Jun 2023

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

New research is increasing our understanding about why some women with the most lethal form of ovarian cancer respond much better to treatment than others.

21 Jun 2023

Early-career scientists chosen for 2023 class of the Pew-Stewart Scholars Program for Cancer Research

The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced today the 2023 class of the Pew-Stewart Scholars Program for Cancer Research.

13 Jun 2023

Women's use of contraceptive pills linked to greater risk of depression

Women who used combined contraceptive pills were at greater risk of developing depression than women who did not, according to a new study from Uppsala University. Contraceptive pills increased women's risk by 73 per cent during the first two years of use.

12 Jun 2023

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

UCSF Medical Center named to Honor Roll of nation's top hospitals

IN8bio opens new cancer research lab in Birmingham's Pepper Place

Black women weigh emerging risks of ‘creamy crack’ hair straighteners

New class of antibody could benefit patients with treatment-resistant cancers

Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer

NK:IO raises £1.2M, bringing total Seed funding to £5.1M, to advance pioneering NK cell therapy

Study illuminates why obesity makes ovarian cancer more deadly

Doctors urge more research on the use of psilocybin and other psychedelics for women’s cancer distress

Immunodiagnosis: Unleashing the potential of personalized immunotherapy

The potential prognostic role of AhRR and PPP1R3C expression in serous ovarian cancer

Synoptic reports improve completeness of pretreatment CT reports in advanced ovarian cancer

Researchers develop first therapy of its kind to treat cisplatin-resistant prostate cancer

Imperial spinout NK:IO awarded £1.6M Innovate UK New Cancer Therapeutics grant for development of pioneering NK cell therapy

Women with certain job roles may be associated with heightened risk of ovarian cancer

Study uncovers three previously unknown membrane proteins in ovarian cancer

Adopting a 30th birthday genetic profile test could save lives and NHS costs

3D models of ovarian cancer reveal how cell’s location can affect tumor biology

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

Early-career scientists chosen for 2023 class of the Pew-Stewart Scholars Program for Cancer Research

Women's use of contraceptive pills linked to greater risk of depression

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in